Skip to main content
Premium Trial:

Request an Annual Quote

Advion, SISCAPA Partner to Offer Assay Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Advion BioServices is offering SISCAPA LC/MS Biomarker assay services under a deal with SISCAPA Assay Technologies announced today.

SISCAPA, short for Stable Isotope Standards with Capture by Anti-Peptide Antibody, is a workflow developed by Leigh Anderson as a mass spectrometry-based method for biomarker validation. As GenomeWeb Daily News' sister publication ProteoMonitor recently reported, Anderson formed SISCAPA Assay Technologies to commercialize the technology.

In a statement today, Anderson said that Advion becomes the first contract research organization to offer SISCAPA assay services.

"By partnering with SISCAPA Assay Technologies, we are able to leverage our expertise in protein and peptide analysis by mass spectrometry and open new areas of testing for our clients," Tom Kurz, president of Advion, said.

The services will be conducted in Advion's LC/MS laboratory in Ithaca, NY. Financial and other terms of the deal were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.